To date, most studies on the cytotoxic, regulatory, and/or immunosuppressive roles of T cells in GBM have focused on conventional T cells that recognize peptide antigens presented by major histocompatibility complex (MHC) molecules. This evidence concerns the gene HLA-C and glioblastoma.